289 related articles for article (PubMed ID: 12115175)
1. Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis.
Munster T; Gibbs JP; Shen D; Baethge BA; Botstein GR; Caldwell J; Dietz F; Ettlinger R; Golden HE; Lindsley H; McLaughlin GE; Moreland LW; Roberts WN; Rooney TW; Rothschild B; Sack M; Sebba AI; Weisman M; Welch KE; Yocum D; Furst DE
Arthritis Rheum; 2002 Jun; 46(6):1460-9. PubMed ID: 12115175
[TBL] [Abstract][Full Text] [Related]
2. Factors Related to Blood Hydroxychloroquine Concentration in Patients With Systemic Lupus Erythematosus.
Yeon Lee J; Lee J; Ki Kwok S; Hyeon Ju J; Su Park K; Park SH
Arthritis Care Res (Hoboken); 2017 Apr; 69(4):536-542. PubMed ID: 27390146
[TBL] [Abstract][Full Text] [Related]
3. Blood concentrations of hydroxychloroquine and its desethyl derivative correlate negatively with the percentage of CD45RO+ cells among CD4+ lymphocytes in hydroxychloroquine-treated lupus patients.
Sailler L; Puissant B; Méliani P; Castex JO; Saivin S; Adoue D; Fournie B; Arlet P; Montastruc JL; Lapeyre-Mestre M; Pourrat J; Blancher A
Ann N Y Acad Sci; 2007 Jun; 1108():41-50. PubMed ID: 17893969
[TBL] [Abstract][Full Text] [Related]
4. Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: a randomized, double-blind six-week trial with eighteen-week extension.
Furst DE; Lindsley H; Baethge B; Botstein GR; Caldwell J; Dietz F; Ettlinger R; Golden HE; McLaughlin GE; Moreland LW; Roberts WN; Rooney TW; Rothschild B; Sack M; Sebba AI; Weisman M; Welch KE; Yocum D
Arthritis Rheum; 1999 Feb; 42(2):357-65. PubMed ID: 10025931
[TBL] [Abstract][Full Text] [Related]
5. Association of Polymorphisms of Cytochrome P450 2D6 With Blood Hydroxychloroquine Levels in Patients With Systemic Lupus Erythematosus.
Lee JY; Vinayagamoorthy N; Han K; Kwok SK; Ju JH; Park KS; Jung SH; Park SW; Chung YJ; Park SH
Arthritis Rheumatol; 2016 Jan; 68(1):184-90. PubMed ID: 26316040
[TBL] [Abstract][Full Text] [Related]
6. Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.
Rainsford KD; Parke AL; Clifford-Rashotte M; Kean WF
Inflammopharmacology; 2015 Oct; 23(5):231-69. PubMed ID: 26246395
[TBL] [Abstract][Full Text] [Related]
7. Determination of the stereoisomers of hydroxychloroquine and its major metabolites in plasma and urine following a single oral administration of racemic hydroxychloroquine.
Iredale J; Fieger H; Wainer IW
Semin Arthritis Rheum; 1993 Oct; 23(2 Suppl 1):74-81. PubMed ID: 8278822
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of a Fast Ultra-High Performance Liquid Chromatography-Fluorescent Method for the Quantification of Hydroxychloroquine and Its Metabolites in Patients With Lupus.
Noé G; Amoura Z; Combarel D; Lori L; Tissot N; Seycha A; Funck-Brentano C; Zahr N
Ther Drug Monit; 2019 Aug; 41(4):476-482. PubMed ID: 30807538
[TBL] [Abstract][Full Text] [Related]
9. Skin and ophthalmic complications of chloroquine and hydroxychloroquine in patients with rheumatoid arthritis and systemic lupus erythematous.
Zamani B; Hasan-Abad AM; Rafizadeh SM; Akbari H; Motedayyen H
J Immunoassay Immunochem; 2024 May; 45(3):178-188. PubMed ID: 38722204
[TBL] [Abstract][Full Text] [Related]
10. Enantioselective determination of hydroxychloroquine and its major metabolites in urine and the observation of a reversal in the (+)/(-)-hydroxychloroquine ratio.
Fieger H; Iredale J; Wainer IW
Chirality; 1993; 5(2):65-70. PubMed ID: 8343344
[TBL] [Abstract][Full Text] [Related]
11. Health status and concomitant prescription of immunosuppressants are risk factors for hydroxychloroquine non-adherence in systemic lupus patients with prolonged inactive disease.
Iudici M; Pantano I; Fasano S; Pierro L; Charlier B; Pingeon M; Dal Piaz F; Filippelli A; Izzo V
Lupus; 2018 Feb; 27(2):265-272. PubMed ID: 28659047
[TBL] [Abstract][Full Text] [Related]
12. Stereoselective determination of hydroxychloroquine and its metabolites in human urine by liquid-phase microextraction and CE.
de Oliveira AR; Cardoso CD; Bonato PS
Electrophoresis; 2007 Apr; 28(7):1081-91. PubMed ID: 17295421
[TBL] [Abstract][Full Text] [Related]
13. Determination of hydroxychloroquine and its major metabolites in plasma using sequential achiral-chiral high-performance liquid chromatography.
Iredale J; Wainer IW
J Chromatogr; 1992 Jan; 573(2):253-8. PubMed ID: 1601957
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of hydroxychloroquine sulphate in rheumatoid arthritis: a randomized, double-blind, placebo controlled clinical trial--an Indian experience.
Das SK; Pareek A; Mathur DS; Wanchu A; Srivastava R; Agarwal GG; Chauhan RS
Curr Med Res Opin; 2007 Sep; 23(9):2227-34. PubMed ID: 17692155
[TBL] [Abstract][Full Text] [Related]
15. Determinants of hydroxychloroquine blood concentration variations in systemic lupus erythematosus.
Jallouli M; Galicier L; Zahr N; Aumaître O; Francès C; Le Guern V; Lioté F; Smail A; Limal N; Perard L; Desmurs-Clavel H; Le Thi Huong D; Asli B; Kahn JE; Pourrat J; Sailler L; Ackermann F; Papo T; Sacré K; Fain O; Stirnemann J; Cacoub P; Leroux G; Cohen-Bittan J; Sellam J; Mariette X; Blanchet B; Hulot JS; Amoura Z; Piette JC; Costedoat-Chalumeau N;
Arthritis Rheumatol; 2015 May; 67(8):2176-84. PubMed ID: 25989906
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics of hydroxychloroquine in patients with rheumatoid arthritis.
Carmichael SJ; Charles B; Tett SE
Ther Drug Monit; 2003 Dec; 25(6):671-81. PubMed ID: 14639053
[TBL] [Abstract][Full Text] [Related]
17. Treatment with cyclosporin switching to hydroxychloroquine in patients with rheumatoid arthritis.
Kim WU; Seo YI; Park SH; Lee WK; Lee SK; Paek SI; Cho CS; Song HH; Kim HY
Ann Rheum Dis; 2001 May; 60(5):514-7. PubMed ID: 11302876
[TBL] [Abstract][Full Text] [Related]
18. Stereoselective disposition of hydroxychloroquine and its metabolite in rats.
Wei Y; Nygard GA; Ellertson SL; Khalil SK
Chirality; 1995; 7(8):598-604. PubMed ID: 8593253
[TBL] [Abstract][Full Text] [Related]
19. Hydroxychloroquine may be associated with reduced risk of coronary artery diseases in patients with rheumatoid arthritis: A nationwide population-based cohort study.
Hung YM; Wang YH; Lin L; Wang PYP; Chiou JY; Wei JC
Int J Clin Pract; 2018 May; 72(5):e13095. PubMed ID: 29691971
[TBL] [Abstract][Full Text] [Related]
20. Etanercept in combination with sulfasalazine, hydroxychloroquine, or gold in the treatment of rheumatoid arthritis.
O'Dell JR; Petersen K; Leff R; Palmer W; Schned E; Blakely K; Haire C; Fernandez A
J Rheumatol; 2006 Feb; 33(2):213-8. PubMed ID: 16358366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
